Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,777
Views
21
CrossRef citations to date
0
Altmetric
Original Research

IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population

Clément BarjonInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Henri-Alexandre MichaudInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Angeline FagesInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Cécile DejouOREGA Biotech, Ecully, France
,
Alexandre ZampieriInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Laetitia TheyInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Aurélie GennetierInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Françoise SanchezInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Laurent GrosInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
,
Jean-François EliaouInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France;OREGA Biotech, Ecully, France;Département d'Immunologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, France
,
Nathalie BonnefoyInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France
&
Virginie LafontInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM), Montpellier, France;Département d'Immunologie, Centre Hospitalier Universitaire de Montpellier et Faculté de Médecine, Université de Montpellier, Hôpital Saint-Eloi, Montpellier cedex 5, FranceCorrespondence[email protected]
 show all
Article: e1379642 | Received 12 Jul 2017, Accepted 10 Sep 2017, Published online: 04 Oct 2017

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now

Articles from other publishers (20)

Haeyoun Choi, Tai-Gyu Kim, Sin-Soo Jeun & Stephen Ahn. (2023) Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy. Cancer Letters 571, pages 216335.
Crossref
Claudia Giannotta, Federica Autino & Massimo Massaia. (2023) Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?. Frontiers in Immunology 14.
Crossref
Zhifei Gao, Yifeng Bai, Anqi Lin, Aimin Jiang, Chaozheng Zhou, Quan Cheng, Zaoqu Liu, Xin Chen, Jian Zhang & Peng Luo. (2023) Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment. Molecular Cancer 22:1.
Crossref
Shuang Liang, Tianhui Dong, Keli Yue, Haitao Gao, Ning Wu, Ruoyang Liu, Yan Chang, Le Hao, Lijuan Hu, Ting Zhao, Qian Jiang, Xiao-Jun Huang & Jiangying Liu. (2022) Identification of the immunosuppressive effect of γδ T cells correlated to bone morphogenetic protein 2 in acute myeloid leukemia. Frontiers in Immunology 13.
Crossref
Yuan Song, Yonghao Liu, Huey Yee Teo & Haiyan Liu. (2022) Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Yue Wang, Yi Xu, Hui Chen, Jianmin Zhang & Wei He. (2022) Novel insights based on the plasticity of γδ T cells in the tumor microenvironment. Exploration of Immunology, pages 98-132.
Crossref
Chenxiao Liu, Karolina Skorupinska-Tudek, Sven-Göran Eriksson & Ingela Parmryd. (2022) Potentiating Vγ9Vδ2 T cell proliferation and assessing their cytotoxicity towards adherent cancer cells at the single cell level. Biology Open 11:1.
Crossref
Franziska Brauneck, Pauline Weimer, Julian Schulze zur Wiesch, Katja Weisel, Lisa Leypoldt, Gabi Vohwinkel, Britta Fritzsche, Carsten Bokemeyer, Jasmin Wellbrock & Walter Fiedler. (2021) Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma. Frontiers in Medicine 8.
Crossref
Emilie Barsac, Carolina de Amat Herbozo, Loïc Gonzalez, Thomas Baranek, Thierry Mallevaey & Christophe Paget. (2021) Regulation and Functions of Protumoral Unconventional T Cells in Solid Tumors. Cancers 13:14, pages 3578.
Crossref
Yi Zhao, Zhiyu Zhang, Wenbin Lei, Yi Wei, Renqiang Ma, Yihui Wen, Fanqin Wei, Jun Fan, Yang Xu, Lin Chen, Kexing Lyu, Hanqing Lin, Weiping Wen & Wei Sun. (2021) IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer. Frontiers in Oncology 11.
Crossref
Rebecca E. Burnham, Jaquelyn T. Zoine, Jamie Y. Story, Swetha N. Garimalla, Greg Gibson, Aaron Rae, Erich Williams, Lisa Bixby, David Archer, Christopher B. Doering & H. Trent Spencer. (2020) Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy. Frontiers in Medicine 7.
Crossref
Guoming Hu, Pu Cheng, Jun Pan, Shimin Wang, Qiannan Ding, Zhou Jiang, Lu Cheng, Xuan Shao, Liming Huang & Jian Huang. (2020) An IL6–Adenosine Positive Feedback Loop between CD73+ γδTregs and CAFs Promotes Tumor Progression in Human Breast Cancer. Cancer Immunology Research 8:10, pages 1273-1286.
Crossref
Ghita Chabab, Clément Barjon, Nathalie Bonnefoy & Virginie Lafont. (2020) Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy. Frontiers in Immunology 11.
Crossref
Ghita Chabab, Florence Boissière-Michot, Caroline Mollevi, Jeanne Ramos, Evelyne Lopez-Crapez, Pierre-Emmanuel Colombo, William Jacot, Nathalie Bonnefoy & Virginie Lafont. (2020) Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers. Cells 9:6, pages 1537.
Crossref
Ghita Chabab, Clément Barjon, Naoill Abdellaoui, Lucie Salvador-Prince, Cécile Dejou, Henri-Alexandre Michaud, Florence Boissière-Michot, Evelyne Lopez-Crapez, William Jacot, Didier Pourquier, Nathalie Bonnefoy & Virginie Lafont. (2020) Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. Journal of Leukocyte Biology 107:6, pages 1057-1067.
Crossref
Jen-Hwey Chiu, Ling-Ming Tseng, Tzu-Ting Huang, Chun-Yu Liu, Jir-You Wang, Ching-Po Huang, Yi-Fang Tsai & Chih-Yi Hsu. (2020) MEGF11 is related to tumour recurrence in triple negative breast cancer via chemokine upregulation. Scientific Reports 10:1.
Crossref
Hannah Jonescheit, Hans-Heinrich Oberg, Daniel Gonnermann, Martin Hermes, Vjola Sulaj, Christian Peters, Dieter Kabelitz & Daniela Wesch. (2020) Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells. Cells 9:5, pages 1140.
Crossref
Karin Schilbach, Naomi Krickeberg, Carlotta Kaißer, Simon Mingram, Janika Kind, Gabrielle M. Siegers & Hisayoshi Hashimoto. (2020) Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength. Cancer Immunology, Immunotherapy 69:4, pages 593-610.
Crossref
Barbara Castella, Myriam Foglietta, Chiara Riganti & Massimo Massaia. (2018) Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression. Frontiers in Immunology 9.
Crossref
Christian Peters, Dieter Kabelitz & Daniela Wesch. (2018) Regulatory functions of γδ T cells. Cellular and Molecular Life Sciences 75:12, pages 2125-2135.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.